These were the worst performing ASX 200 shares in December

These ASX 200 shares had a tough month…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

December certainly was a great month for the S&P/ASX 200 Index (ASX: XJO). The benchmark index rose 2.6% over the period to end it at 7,444.6 points.

Unfortunately, not all shares were able to climb higher with the market. Here's why these were the worst performing ASX 200 shares in December:

A young woman with tattoos puts both thumbs down and scrunches her face.

Image source: Getty Images

Magellan Financial Group Ltd (ASX: MFG)

The Magellan share price was the worst performer on the ASX 200 last month with a 34.4% decline. Investors were selling off the fund manager's shares after it announced the termination of the St James's Place mandate. Magellan advised that the mandate represents approximately 12% of the company's current annual revenues. Though, due to the timing of its termination, it is only anticipated to impact Magellan's FY 2022 revenues by 6%. Investors appear concerned more mandates could be lost, particularly given the very poor performance of its flagship fund.

Afterpay Ltd (ASX: APT)

The Afterpay share price was some way behind as the next worst performer with a decline of 17%. The buy now pay later (BNPL) provider's shares were sold down after the Square share price tumbled lower. As Afterpay shareholders have voted in favour of being acquired by Square in an all-scrip deal, its shares rise and fall with the Square share price.

Mesoblast Limited (ASX: MSB)

The Mesoblast share price was a poor performer and dropped 12.7% during the month. Investors were selling off the allogeneic cellular medicines developer's shares after Novartis terminated an agreement that could have been worth ~US$1.2 billion. The two parties were looking at Mesoblasts' remestemcel-L as a treatment for acute respiratory distress syndrome (ARDS) due to COVID-19. Novartis ended the agreement after reviewing some disappointing trial results.

Zip Co Ltd (ASX: Z1P)

The Zip share price was out of form again and dropped 11.5% last month. This was driven by weakness in the tech sector and concerns over news that US authorities are launching an investigation into the BNPL sector. The US Consumer Financial Protection Bureau is looking to see if BNPL players need to be better regulated and if US consumers are adequately protected.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns and has recommended Afterpay Limited and ZIPCOLTD FPO. The Motley Fool Australia owns and has recommended Afterpay Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Fallers

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why KMD, Tamboran Resources, Whitehaven Coal, and WiseTech Global shares are falling today

These shares are out of form on Thursday. What's going on?

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why Dateline, Karoon Energy, Lindian, and PEXA shares are falling today

These shares are missing out on the good times on Wednesday. But why?

Read more »

A man slumps crankily over his morning coffee as it pours with rain outside.
Share Fallers

These were the worst-performing ASX 200 shares in March

These shares were out of form in March. Let's see why investors sold them off.

Read more »

Disappointed man with his head on his hand looking at a falling share price his a laptop.
Share Fallers

Why 4DMedical, New Hope, Santos, and St George Mining shares are dropping today

These shares are under pressure on Tuesday. But why?

Read more »

A woman is excited as she reads the latest rumour on her phone.
Share Fallers

These 3 dirt-cheap ASX shares are tipped to climb another 50-90%

These shares are now trading at super low prices.

Read more »

Shot of a young businesswoman looking stressed out while working in an office.
Share Fallers

Why 4DMedical, Brainchip, Catapult, and Star Entertainment shares are falling today

These shares are starting the week in the red. But why>

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why DroneShield, Hub24, Syrah, and Weebit Nano shares are sinking today

These shares are ending the week in the red. But why?

Read more »

A worried woman sits at her computer with her hands clutched at the bottom of her face.
Share Fallers

These 3 ASX 200 shares have hit fresh multi-year lows: Buy, sell or hold?

One of these stocks has crashed over 50% over the past year alone.

Read more »